A pharmaceutical composition for angiotensin ii-mediated...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/415 (2006.01) A61K 31/495 (2006.01) A61K 45/06 (2006.01)

Patent

CA 2125251

This invention relates to a pharmaceutical composition of angiotensin II-mediated diseases, which comprises a compound having angiotensin II antagonistic activity of the formula (See formula I) wherein R1 is H or an optionally substituted hydrocarbon residue; R2 is an optionally esterified carboxyl group; R3 is a group capable of forming an anion or a group convertible thereinto; X is a covalent bond between the 2 phenyl rings or a spacer having a chain length of 1 to 2 atoms as the linear moiety between the adjoining phenylene group and phenyl group; n is 1 or 2; the ring A is a benzene ring having 1 or 2 optional substituents in addition to R2; and Y is a bond, -O-, -S(O)m-(wherein m is 0, 1 or 2) or -N(R4)- (wherein R4 is H or an optionally substituted alkyl group), or a pharmaceutically acceptable salt thereof in combination with a compound having diuretic activity or a compound having calcium antagonistic activity.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

A pharmaceutical composition for angiotensin ii-mediated... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A pharmaceutical composition for angiotensin ii-mediated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A pharmaceutical composition for angiotensin ii-mediated... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1925457

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.